TrialThrombosis and haemostasis2018

Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study).

Wael Sumaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.